OTHER PSYCHEDELICS

Neurotropic’s® Commitment to Psychedelic Medicine Research and Therapies

​

Psychedelic medicine offers an exciting frontier in wellness and mental health. Our primary commitment is to the well-being and holistic healing of our patients. Over the years, we've been at the forefront of harnessing the therapeutic potential of ketamine infusions, a groundbreaking approach that has shown significant promise for various mental health conditions.

​

Beyond ketamine, we recognize the emerging therapeutic potential of other psychedelic medicines. We've diligently followed, and in some cases, even contributed to the scientific research and clinical trials surrounding these substances. Our team is continuously exploring the potential benefits, mechanisms of action, and safety profiles of various psychedelic agents, understanding their unique therapeutic attributes and the contexts in which they may be beneficial.

​

As the global perspective on psychedelic medicine evolves, so does the legal landscape. We are excited and fully prepared to implement novel therapeutic protocols in our clinic, drawing from the pool of these promising psychedelic treatments as soon as they receive the necessary legal and regulatory approvals. We believe that the integration of these therapies can offer our patients a broader spectrum of innovative and effective treatments.

​

In this ever-changing field, we pledge to maintain our rigorous standards for safety, research-backed practices, and patient-centered care. Our ultimate goal remains unwavering: to provide the best possible therapeutic outcomes for those who entrust us with their care. We are hopeful and enthusiastic about what the future holds for psychedelic medicine, and we're committed to leading the way in introducing these novel treatments to our community as the legal framework permits.